In this article we present the list of Top 10 Healthcare Stocks To Buy for the Future. Click to skip ahead and see the Top 5 Healthcare Stocks for the...
Keep Reading →
November 29 - Hedge Fund Analysis, Hedge Funds, News - Comments
Balyasny Gains in First Half After Losses Prompted Reorganization in 2018 (Reuters) BOSTON (Reuters) – Balyasny Asset Management, a Chicago-based...
Keep Reading →
July 15 - Hedge Funds, Insider Trading - Comments
Cytokinetics Inc (NASDAQ:CYTK): Mark Lampert’s Biotechnology Value Fund LP filed an amended 13D. You can check out Biotechnology Value Fund LP...
Keep Reading →
December 1 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE...
Keep Reading →
May 15 - Hedge Funds - Comments
1. US Stock Market: “U.S. stocks retreated on Tuesday as a spate of tepid corporate earnings weighed on the broader market. The Dow Jones...
Keep Reading →
April 18 - Commodities, Gold, Market Movers, News, Tech - Comments
In another round of filings with the Securities and Exchange Commission, Steven Cohen and his fund, SAC Capital Advisors, have disclosed 4 new moves:...
Keep Reading →
April 9 - Hedge Funds, News - Comments
Mark Lampert, the founder and manager of Biotechnology Value Fund, is bullish on Cytokinetics, Inc. (NASDAQ:CYTK). According to a recent filing with...
Keep Reading →
March 26 - Hedge Funds, News - Comments
Is BioDelivery Sciences International, Inc. (NASDAQ:BDSI) a good investment? At the moment, there are many indicators market participants can use to...
Keep Reading →
September 17 - News - Comments
Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) a good investment? Now, according to many investors, hedge funds are assumed to be overrated, outdated investment...
Keep Reading →
September 17 - News - Comments
Just after the successful acquisition of Onyx Pharmaceuticals and positive results on AMG-145, a cholesterol-lowering experimental drug, Amgen, Inc...
Keep Reading →
September 11 - News - Comments
Before the market opened last Tuesday, Cytokinetics, Inc. (NASDAQ:CYTK) and Amgen, Inc. (NASDAQ:AMGN) scrambled to spin the results of their Phase 2...
Keep Reading →
September 10 - News - Comments
With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into...
Keep Reading →
September 9 - News - Comments
College football arrived in a big way over the past week or so, with plenty of big plays already. Health-care stocks had their fair share of big plays...
Keep Reading →
September 7 - News - Comments
Should Pain Therapeutics, Inc. (NASDAQ:PTIE) investors track the following data? In the eyes of many investors, hedge funds are viewed as overrated,...
Keep Reading →
September 6 - News - Comments
Is ArQule, Inc. (NASDAQ:ARQL) a good investment? In the 21st century investor’s toolkit, there are many metrics shareholders can use to monitor stocks...
Keep Reading →
September 3 - News - Comments
“Bubble” can be a provocative word in investing circles. Think of all that comes to mind when you hear it — perhaps other words like...
Keep Reading →
August 27 - News - Comments
What’s a smart Cytokinetics, Inc. (NASDAQ:CYTK) investor to do? In the eyes of many of your peers, hedge funds are seen as useless, old investment...
Keep Reading →
August 22 - News - Comments
Healthcare is the most happening industry these days with new drugs on the line and investors injecting cash into companies with greater speculative growth...
Keep Reading →
August 3 - News - Comments
Small cap stocks are a bit riskier, but offer more growth than the stable large cap ones. The biotech sector in U.S. has a number of small cap stocks...
Keep Reading →
July 17 - News - Comments
Only a handful of stocks have gained 200% in 2013, and five of those stocks are in the biotechnology industry. Perhaps you already own one, or maybe...
Keep Reading →
July 12 - News - Comments
Is OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) a cheap investment today? Money managers are getting more bullish. The number of long hedge fund bets improved...
Keep Reading →
July 8 - News - Comments
Cytokinetics, Inc. (NASDAQ:CYTK) was in 8 hedge funds’ portfolio at the end of March. CYTK shareholders have witnessed an increase in support from...
Keep Reading →
June 24 - News - Comments
Is Cytokinetics, Inc. (NASDAQ:CYTK) the right pick for your portfolio? Prominent investors are in a bullish mood. The number of bullish hedge fund bets...
Keep Reading →
June 17 - News - Comments
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) shareholders have witnessed a decrease in hedge fund sentiment of late; stagnant interest is a...
Keep Reading →
June 13 - News - Comments
Is Pain Therapeutics, Inc. (NASDAQ:PTIE) a buy, sell, or hold? The smart money is in a bearish mood. The number of long hedge fund positions were trimmed...
Keep Reading →
June 10 - News - Comments
A failing heart is a lot like a glass Heinz Ketchup bottle. Squeezing the bottle isn’t very efficient, so you smack that strategically placed ...
Keep Reading →
April 29 - News - Comments
Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) a marvelous investment today? Money managers are becoming less confident. The number of bullish hedge fund...
Keep Reading →
April 13 - News - Comments
Don’t settle for ordinary quarterly reports. Every week, I take a look at three companies that beat market expectations, since I believe that it...
Keep Reading →
February 11 - News - Comments